❓ WA Parliamentary Question on Notice regarding pharmacological treatments for gender dysphoria provided to minors in WA during 2025. The Minister for Health provided data on prescriptions of Leuprorelin acetate, Oestradiol, Spironolactone and Testosterone.
AnsweredQoN 1228Legislative Council
QuestionView source ↗
I refer to pharmacological treatments for gender dysphoria provided to minors in Western Australia, and I ask, for the period between 1 January 2025 and 31 December 2025, please provide the following: (a) what medications, by active ingredient, were prescribed to persons under 18 years for puberty suppression or gender-related hormone therapy; (b) for each medication identified in (a), how many prescriptions to persons under 18 years were recorded; and (c) in reference to (b) what was the age breakdown of these patients: (i) under 12 years old; (ii) between 12 and 15 years of age; and (iii) between 16 and 17 years of age?
AnswerView source ↗
Answered
14 April 2026
Responded by
Parliamentary Secretary to the Minister for Health
Response time
8 days
(A) Leuprorelin acetate, Oestradiol, Spironolactone and Testosterone.
(B-C)
Leuprorelin acetate: 11
Oestradiol: 14
Spironolactone: 5
Testosterone: 17
(B-C)
Leuprorelin acetate: 11
Oestradiol: 14
Spironolactone: 5
Testosterone: 17
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.